Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Kaiser Permanente
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of Nebraska
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
University of Alabama at Birmingham
Instituto do Cancer do Estado de São Paulo
Columbia University
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Universidade Federal de Pernambuco
University of Modena and Reggio Emilia
Beijing Friendship Hospital
Istituti Clinici Scientifici Maugeri SpA
M.D. Anderson Cancer Center
University Medical Center Groningen
Stanford University
Institut Bergonié
Zhujiang Hospital
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Stanford University
University of Chicago
Marmara University
Peking University
Rutgers, The State University of New Jersey